Gastric Function Test Market
Number of pages: 100 | Report Format: PDF | Published date: June 01, 2023
Historical Years – 2021 | Base Year – 2022 | Forecasted Years – 2023 to 2031
|
Report Attribute |
Details |
|
CAGR |
4.4% |
|
Base Year for Estimation |
2022 |
|
Forecast Period |
2023 to 2031 |
|
Historical Year |
2021 |
|
Segments Covered |
Test Type, Application, End User, and Region |
|
Regional Scope |
North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa |
According to the deep-dive market assessment study by Growth Plus Reports, the gastric function test market is expected to register a revenue CAGR of 4.4% during the forecast period.
Gastric Function Test Market Fundamentals
A gastric function test is a diagnostic procedure used to assess the performance and functionality of the stomach. These tests provide valuable insights into the various aspects of gastric function and can aid in diagnosing and managing gastric disorders. The gastric emptying test gauges the rate at which the stomach empties its contents into the small intestine and hence is a frequently used gastric function test. The gastric acid secretion test is a different type of test that gauges how much acid the stomach produces and aids in diagnosing hyperacidity and gastric ulcers. Endoscopically acquired gastric biopsies allow the microscopic study of the stomach tissue to detect diseases like gastritis or stomach cancer. While the breath test for Helicobacter pylori looks for this bacterium linked to gastric ulcers, gastric manometry gauges the pressure and muscular activity of the stomach. These tests are essential for comprehending and controlling gastrointestinal diseases, helping medical practitioners identify their patients correctly, and creating effective treatment regimens for them.
Gastric Function Test Market Dynamics
The global gastric function test market is influenced by several key drivers that contribute to its growth and development. The increased prevalence of gastrointestinal illnesses is significantly fueling the global gastric function test market such as gastroparesis, gastroesophageal reflux disease (GERD), peptic ulcers, and stomach cancer. There is an increasing need for diagnostic procedures that can precisely evaluate stomach function and support efficient treatment planning due to the rising prevalence of these disorders. The primary drivers of the market include the increasing prevalence of GI disorders such as C. difficile, salmonella, shigella, and H. pylori, as well as the spike in GI infection diagnosis and rising awareness. 1 in 6 Americans, according to the CDC, have C. difficile infection. Some of the major drivers propelling the segment over the forecast period include the rising incidence of colorectal cancers, government programs to manage cancer, and technical breakthroughs in diagnosing gastrointestinal cancer. For instance, more than 1.9 million colorectal cancer cases were reported worldwide in 2020. A few genetic variables have been linked to gastrointestinal conditions like IBS and colorectal cancer. According to the study, several GI malignancies and illnesses are frequently brought on by inherited gene mutations and gene-gene interactions. Governmental and non-governmental organizations and market participants are adopting specific initiatives for gastrointestinal genetic testing. For instance, GI OnDemand and Ambry Genetics established a cooperation in March 2021 to expand the testing options and genetic counseling into gastrointestinal clinics across the United States. Additionally, it is projected that continued regulatory approvals and the product introduction of breakthrough diagnostic tests for gastrointestinal illnesses will promote market expansion during the projection period. For instance, Biomerica, Inc. got the CE mark in May 2022 for their hp+detect diagnostic test for identifying H. pylori bacteria in the European Union and other nations. The most frequent cause of stomach cancer risk is H. pylori bacteria. The shift towards personalized medicine and precision diagnostics has influenced the gastric function test market. Healthcare providers are increasingly adopting a personalized approach to diagnose and treat gastric disorders based on individual patient characteristics and specific diagnostic test results. This approach drives the demand for gastric function tests that provide accurate and personalized information to guide treatment decisions.
However, despite the rising prevalence of gastric disorders, there may be limited awareness among the general population regarding the importance of gastric function tests in diagnosing and managing these conditions. A lack of awareness can hinder the adoption of gastric function tests and limit the growth of the global market. Additionally, accessibility to healthcare services, including specialized diagnostic facilities, may be limited in certain regions, which can impact the uptake of these tests.
Gastric Function Test Market Ecosystem
The global gastric function test market is analyzed from the following perspectives: test type, application, end user, and region.
Gastric Function Test Market by Test Type
Based on the test type, the global gastric function test market is segmented into helicobacter pylori tests, gastric motility tests, gastric emptying tests, gastric acid secretion tests, and others.
The gastric emptying tests segment accounts for the largest revenue share in the global gastric function test market. The gastric emptying test is frequently employed to evaluate the rate at which the stomach empties its contents into the small intestine. It is often used to diagnose gastroparesis and assess delayed gastric emptying. Gastric emptying studies can be performed using several types of meals or liquids, and the choice depends on factors such as local protocols and patient-specific considerations.
Gastric Function Test Market by Application
Based on the application, the global gastric function test market is segmented into gastric cancer, gastroesophageal reflux disease (GERD), gastroparesis, peptic ulcers, and others.
The gastroesophageal reflux disease (GERD) segment accounts for the global gastric function test market. One of the most prevalent gastric conditions worldwide is gastroesophageal reflux disease (GERD). In the United States, GERD affects an estimated 20% of the adult population. It is one of the most common gastrointestinal disorders in the country. GERD is a chronic digestive disorder characterized by the reflux of stomach acid and other stomach contents back into the esophagus, leading to symptoms such as heartburn, regurgitation, and chest pain. GERD is estimated to affect a sizable portion of the global population, with varying prevalence rates depending on the region.
Gastric Function Test Market by End User
Based on the end user, the global gastric function test market is segmented into hospitals, diagnostic laboratories, research institutes, and others.
The hospital segment accounts for the largest revenue share in the global gastric function tests market. Gastric function tests play a crucial role in hospitals for the evaluation, diagnosis, and management of various gastric conditions. Gastric function tests assist healthcare providers in developing appropriate treatment plans for patients with gastric disorders.
Gastric Function Test Market by Region
Geographically, the global gastric function test market has been segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa.
North America accounts for the largest revenue share in the global gastric function test market. North America has a high prevalence of gastric disorders such as gastroparesis, GERD, peptic ulcers, and gastric cancer. The increasing incidence of these conditions creates a robust demand for diagnostic tests, including gastric function tests, in the region.The region is at the forefront of technological advancements in healthcare. North America has quickly adopted and integrated innovative diagnostic technologies into clinical practice. The availability of advanced diagnostic systems, such as wireless motility capsules, high-resolution manometry, and molecular diagnostics, drives the growth of the gastric function test market. There is a growing emphasis on digestive health and the impact of gastric disorders on overall well-being in North America. Patients are becoming more aware while seeking medical attention for digestive issues, leading to an increased demand for accurate diagnostic tests, including gastric function tests. The regulatory environment in North America, particularly in the United States, supports the development and commercialization of diagnostic tests. Regulatory agencies like the U.S. Food and Drug Administration (FDA) provide clear pathways for test approvals and ensure patient safety. This supportive regulatory framework facilitates market growth by encouraging innovation and market access.
The gastric function test market in the Asia Pacific region is expected to experience significant growth due to several factors. The Asia Pacific region has witnessed a rise in the prevalence of gastric disorders such as GERD, peptic ulcers, gastritis, and gastric cancer. This increase can be attributed to factors such as changing lifestyles, dietary habits, and an aging population. The growing incidence of these conditions drives the demand for diagnostic tests, including gastric function tests, in the region.
Gastric Function Test Market Competitive Landscape
The prominent players operating in the global gastric function test market are: -
Gastric Function Test Market Strategic Developments
Various medical treatments known as "gastric function tests" are performed to evaluate how well the stomach works. These tests can aid in the diagnosis and follow-up of numerous illnesses and ailments of the stomach.
The global gastric function test market during the forecast period is expected to grow at a revenue CAGR of 4.4%.
Thermo Fisher Scientific Inc., BIOMERIEUX, F. Hoffmann-La Roche Ltd., Beckman Coulter, Inc., and DiaSorin S.p.A are the major players in the gastric function test market.
The Asia Pacific region is projected to grow at a high revenue CAGR in the global gastric function test market.
The cost of gastric function tests, including the equipment, materials, and specialized expertise required, are some of the factors restricting the global gastric function test market growth to its full potential.
*Insights on financial performance are subject to the availability of information in the public domain